Effects of Ozanimod on Immune-mediated Mechanisms of Neurodegeneration in Multiple Sclerosis - a Preclinical Study
Clinical trial NCT05245344 · UNKNOWN
Trial details
- NCT number
- NCT05245344
- Sponsor
- Neuromed IRCCS
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-04-01
- Primary completion
- 2023-06-30
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.